Belmora has petitioned the Fourth Circuit to reconsider its decision that Bayer did not need to use the Flanax mark in the US to sue under the Lanham Act. Belmora says the court “appeared to be motivated by a sense of ethical outrage”
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Tarun Gandhi joins us for our ‘Five minutes with’ series to discuss the biggest misconception about IP, the importance of staying curious, and his biggest inspiration
Latham & Watkins client CoStar filed an opposition brief against Crexi, arguing that their motion to stay is a distraction from an imminent copyright trial
Partners at law firm Silva reveal how their recent geographical indication win in India for Chilean Pisco paves the way for future victories internationally